FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 46 filers reported holding FOGHORN THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,324,215 | -29.0% | 264,843 | 0.0% | 1.13% | -19.4% |
Q2 2023 | $1,864,495 | +113450.2% | 264,843 | 0.0% | 1.40% | +8.7% |
Q1 2023 | $1,642 | -2.8% | 264,843 | 0.0% | 1.29% | +7.7% |
Q4 2022 | $1,690 | -99.9% | 264,843 | 0.0% | 1.19% | -25.4% |
Q3 2022 | $2,272,000 | -41.4% | 264,843 | -7.0% | 1.60% | -43.2% |
Q2 2022 | $3,874,000 | -13.5% | 284,843 | -3.2% | 2.82% | -12.6% |
Q1 2022 | $4,480,000 | -37.6% | 294,143 | -6.4% | 3.22% | -30.4% |
Q4 2021 | $7,184,000 | +64.2% | 314,143 | 0.0% | 4.63% | +55.6% |
Q3 2021 | $4,376,000 | +30.5% | 314,143 | 0.0% | 2.98% | +48.5% |
Q2 2021 | $3,352,000 | -19.0% | 314,143 | 0.0% | 2.00% | -18.4% |
Q1 2021 | $4,140,000 | -35.0% | 314,143 | 0.0% | 2.46% | -33.0% |
Q4 2020 | $6,368,000 | – | 314,143 | – | 3.67% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Capital LLC | 1,261,261 | $17,153,000 | 14.59% |
Flagship Pioneering Inc. | 12,674,120 | $172,368,000 | 6.49% |
Birchview Capital, LP | 284,843 | $3,874,000 | 2.82% |
Artal Group S.A. | 1,720,720 | $23,402,000 | 1.25% |
Alphabet Inc. | 500,901 | $6,812,000 | 0.37% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 777,525 | $10,574,000 | 0.22% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 382,940 | $5,208,000 | 0.08% |
XTX Topco Ltd | 11,436 | $156,000 | 0.06% |
Virtus ETF Advisers LLC | 8,198 | $111,000 | 0.04% |
Dynamic Technology Lab Private Ltd | 20,551 | $279,000 | 0.03% |